Regular aspirin use and risk of age-related macular degeneration

American Journal of Ophthalmology

Volumn 156, Issue 2, 2013, Pages

  Sobrin, Lucia ^a   Seddon, Johanna M ^b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

CARDIOVASCULAR DISEASE; DRUG USE; EXUDATIVE MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; HUMAN; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT;

EID: 84880551210     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.04.023     Document Type: Editorial

References (15)

1. ABCnews.com. Aspirin use tied to age-related vision loss. Available at http://abcnews.go.com/Health/EyeHealth/aspirin-tied-vision-loss-age/story?id= 18277655. Accessed April 15, 2013.
2. G. Liew, P. Mitchell, T.Y. Wong, E. Rochtchina, and J.J. Wang The association of aspirin use with age-related macular degeneration JAMA Intern Med 173 4 2013 258 264
3. P.T. de Jong, U. Chakravarthy, and M. Rahu Associations between aspirin use and aging macula disorder: the European Eye Study Ophthalmology 119 1 2012 112 118
4. B.E. Klein, K.P. Howard, R.E. Gangnon, J.O. Dreyer, K.E. Lee, and R. Klein Long-term use of aspirin and age-related macular degeneration JAMA 308 23 2012 2469 2478
5. D.H. Anderson, M.J. Radeke, and N.B. Gallo The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited Prog Retin Eye Res 29 2 2010 95 112
6. U. Chakravarthy, T.Y. Wong, and A. Fletcher Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis BMC Ophthalmol 10 2010 31
7. W.G. Christen, R.J. Glynn, and U.A. Ajani Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians Arch Ophthalmol 119 8 2001 1143 1149
8. W.G. Christen, R.J. Glynn, E.Y. Chew, and J.E. Buring Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women Ophthalmology 116 12 2009 2386 2392
9. C. Baigent, L. Blackwell, and R. Collins Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 9678 2009 1849 1860
10. M. Nelson, C. Reid, and L. Beilin Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE) Drugs Aging 20 12 2003 897 903
11. S. Kaul, and G.A. Diamond Relationship of aspirin use with age-related macular degeneration: association or causation?: comment on "The association of aspirin use with age-related macular degeneration." JAMA Intern Med 173 4 2013 264 266
12. R. Klein, B.E. Klein, and S.C. Jensen Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study Arch Ophthalmol 119 9 2001 1354 1359
13. T.E. Clemons, R.C. Milton, R. Klein, J.M. Seddon, and F.L. Ferris 3rd Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 Ophthalmology 112 4 2005 533 539
14. A.R. Rudnicka, P.K. MacCallum, R. Whitelocke, and T.W. Meade Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study Eye (Lond) 24 7 2010 1199 1206
15. N. Cheung, W.T. Tay, G.C. Cheung, J.J. Wang, P. Mitchell, and T.Y. Wong Is aspirin intake associated with early age-related macular degeneration? The Singapore Indian Eye Study Br J Ophthalmol 2013 10.1136/bjophthalmol-2012-302253